🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Wuhan Healthgen Biotechnology Corp. (SHA:688765)
China flag China · Delayed Price · Currency is CNY
25.67
-1.60 (-5.87%)
At close: Nov 20, 2026

SHA:688765 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,023669.44160.4235.97387.56243.41
Cash & Short-Term Investments
1,537669.44160.4235.97387.56243.41
Cash Growth
1061.18%317.35%-32.02%-39.11%59.22%61.51%
Accounts Receivable
0.490.450.140.20.090.02
Other Receivables
11.790.350.350.290.77
Receivables
1.482.230.490.550.380.79
Inventory
242.18119.3250.0235.7325.6612.52
Other Current Assets
100.241,37126.4316.4234.7826.49
Total Current Assets
1,8812,162237.34288.67448.38283.21
Property, Plant & Equipment
1,8641,264733.42606.23580.78208.24
Other Intangible Assets
83.1284.4287.3966.2468.0824.53
Long-Term Deferred Charges
-2.943.560.07--
Other Long-Term Assets
22.34189.530.10.995.4377.16
Total Assets
3,8513,7031,062962.21,103593.13

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
62.53370.36175.9105.77169.84122.1
Accrued Expenses
51.0813.198.789.567.886.05
Short-Term Debt
4-10.01---
Current Portion of Long-Term Debt
13.5547.287.361.071.02-
Current Portion of Leases
9.917.782.270.290.550.37
Current Unearned Revenue
12.932.572.451.871.141.1
Other Current Liabilities
473.2612.4125.892.1410.392.02
Total Current Liabilities
627.26453.6232.67120.7190.82131.63
Long-Term Debt
263.71243.9218490.1213.13-
Long-Term Leases
76.8969.3519.292.450.540.39
Long-Term Unearned Revenue
39.0136.6523.0215.831.431.79
Other Long-Term Liabilities
-1.491.491.491.49-
Total Liabilities
1,007805460.46230.58207.41133.81

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
357.5357.5268.05268.05268.05239.13
Additional Paid-In Capital
3,5573,5491,1851,1641,140589.64
Retained Earnings
-1,071-1,008-851.36-699.99-513.03-369.45
Shareholders' Equity
2,8442,898601.35731.62895.26459.32
Total Liabilities & Equity
3,8513,7031,062962.21,103593.13

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
368.05368.33222.9393.9315.250.76
Net Cash (Debt)
1,169301.11-62.53142.04372.31242.65
Net Cash Growth
----61.85%53.44%72.47%
Net Cash Per Share
3.571.06-0.230.531.431.12
Filing Date Shares Outstanding
357.5357.5268.05268.05261.05268.05
Total Common Shares Outstanding
357.5357.5268.05268.05261.05239.13
Working Capital
1,2541,7094.68167.97257.57151.58
Book Value Per Share
7.958.112.242.733.431.92
Tangible Book Value
2,7612,813513.96665.38827.18434.8
Tangible Book Value Per Share
7.727.871.922.483.171.82
Buildings
260.46257.07220.85---
Machinery
499.88494.74471.75---
Construction In Progress
1,218602.79133.75---